Cas:38061-06-2 2-bromo-3,4,6-trichlorophenyl chlorothioformate manufacturer & supplier

We serve Chemical Name:2-bromo-3,4,6-trichlorophenyl chlorothioformate CAS:38061-06-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-bromo-3,4,6-trichlorophenyl chlorothioformate

Chemical Name:2-bromo-3,4,6-trichlorophenyl chlorothioformate
CAS.NO:38061-06-2
Synonyms:2-bromo-3,4,6-trichlorophenyl chlorothioformate
Molecular Formula:C7HBrCl4OS
Molecular Weight:354.86324
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-bromo-3,4,6-trichlorophenyl chlorothioformate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-3,4,6-trichlorophenyl chlorothioformate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-3,4,6-trichlorophenyl chlorothioformate Use and application,2-bromo-3,4,6-trichlorophenyl chlorothioformate technical grade,usp/ep/jp grade.


Related News: While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. 2-bromo-3,4,6-trichlorophenyl chlorothioformate manufacturer API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 2-bromo-3,4,6-trichlorophenyl chlorothioformate supplier API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 2-bromo-3,4,6-trichlorophenyl chlorothioformate vendor While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. 2-bromo-3,4,6-trichlorophenyl chlorothioformate factory By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.